# FDA Inspection 836330 - Biomat USA Inc - June 13, 2013

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/811d846d-80e7-465c-a173-e4e929f9d35c
Source feed: FDA_Inspections

> FDA Inspection 836330 for Biomat USA Inc on June 13, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 836330
- Company Name: Biomat USA Inc
- Inspection Date: 2013-06-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1097910 - 2019-07-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f3eb9376-4a64-4d44-9cc8-96810850fa57)
- [FDA Inspection 944941 - 2015-09-18](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f60a0074-e550-4fda-880b-f2ab34fb7405)
- [FDA Inspection 699913 - 2010-12-01](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/24f3ff5a-e0d5-4d09-b2a5-0d32cab7d684)
- [FDA Inspection 554283 - 2008-12-18](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/63e1572b-c609-4411-a675-b8b9e07344b2)

Company: https://www.keypedia.com/companies/biomat-usa-inc/7be0da5d-e1f3-4896-9aed-6f1dc9c7ed07

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d